UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 70

Sortiert nach

Pathophysiology of thrombotic thrombocytopenic purpura and hemolytic uremic syndrome

Journal of thrombosis and haemostasis, 2018-04, Vol.16 (4), p.618-629

2018

Link zum Volltext

Verfügbarkeit prüfen

High prevalence of hereditary thrombotic thrombocytopenic purpura in central Norway: from clinical observation to evidence

Journal of thrombosis and haemostasis, 2016-01, Vol.14 (1), p.73-82

2016

Link zum Volltext

Verfügbarkeit prüfen

Recombinant ADAMTS13 normalizes von Willebrand factor‐cleaving activity in plasma of acquired TTP patients by overriding inhibitory antibodies

Journal of thrombosis and haemostasis, 2011-05, Vol.9 (5), p.936-944

2011

Link zum Volltext

Verfügbarkeit prüfen

ADAMTS‐13, von Willebrand factor and related parameters in severe sepsis and septic shock

Journal of thrombosis and haemostasis, 2007-11, Vol.5 (11), p.2284-2290

2007

Link zum Volltext

Verfügbarkeit prüfen

Second international collaborative study evaluating performance characteristics of methods measuring the von Willebrand factor cleaving protease (ADAMTS‐13)

Journal of thrombosis and haemostasis, 2008-09, Vol.6 (9), p.1534-1541

2008

Link zum Volltext

Verfügbarkeit prüfen

Morphology studies in type 2 globozoospermia

Fertility and sterility, 2007, Vol.88, p.S367-S367

2007

Link zum Volltext

Verfügbarkeit prüfen

Caplacizumab reduces the frequency of major thromboembolic events, exacerbations and death in patients with acquired thrombotic thrombocytopenic purpura

Journal of thrombosis and haemostasis, 2017-07, Vol.15 (7), p.1448-1452

2017

Link zum Volltext

Verfügbarkeit prüfen

Plasma DNA is elevated in patients with deep vein thrombosis

Journal of vascular surgery. Venous and lymphatic disorders (New York, NY), 2013-10, Vol.1 (4), p.341-348.e1

2013

Link zum Volltext

Verfügbarkeit prüfen

Humoral immune response to ADAMTS13 in acquired thrombotic thrombocytopenic purpura

Journal of thrombosis and haemostasis, 2011-07, Vol.9 (7), p.1285-1291

2011

Link zum Volltext

Verfügbarkeit prüfen

Impaired DNase1‐mediated degradation of neutrophil extracellular traps is associated with acute thrombotic microangiopathies

Journal of thrombosis and haemostasis, 2015-05, Vol.13 (5), p.732-742

2015

Link zum Volltext

Verfügbarkeit prüfen

IgG subclass distribution of anti‐ADAMTS13 antibodies in patients with acquired thrombotic thrombocytopenic purpura

Journal of thrombosis and haemostasis, 2009-10, Vol.7 (10), p.1703-1710

2009

Link zum Volltext

Verfügbarkeit prüfen

CLINICAL ASPECTS OF HEREDITARY AND ACQUIRED THROMBOTIC THROMBOCYTOPENIC PURPURA

Journal of thrombosis and haemostasis, 2007-07, Vol.5, p.SYM-W-064-SYM-W-064

Hovinga, J.A. Kremer

2007

Link zum Volltext

Verfügbarkeit prüfen

Establishment of the WHO 1st International Standard ADAMTS13, plasma (12/252): communication from the SSC of the ISTH

Journal of thrombosis and haemostasis, 2015-06, Vol.13 (6), p.1151-1153

2015

Link zum Volltext

Verfügbarkeit prüfen

Von Willebrand factor binds to surface-bound C1q in vitro

Molecular immunology, 2013-12, Vol.56 (3), p.251-252

2013

Link zum Volltext

Verfügbarkeit prüfen

THE DYNAMIC RANGE OF IMMUNOASSAYS FOR HEPARIN-INDUCED THROMBOCYTOPENIA

Clinica chimica acta, 2024-05, Vol.558, p.118428, Article 118428

2024

Link zum Volltext

Verfügbarkeit prüfen

Thrombotic thrombocytopenic purpura

Journal of thrombosis and haemostasis, 2005-08, Vol.3 (8), p.1663-1675

2005

Link zum Volltext

Verfügbarkeit prüfen

Measurement of ADAMTS‐13 activity in plasma by the FRETS‐VWF73 assay: comparison with other assay methods

Journal of thrombosis and haemostasis, 2006-05, Vol.4 (5), p.1146-1148

2006

Link zum Volltext

Verfügbarkeit prüfen

Hyperbilirubinemia interferes with ADAMTS‐13 activity measurement by FRETS‐VWF73 assay: diagnostic relevance in patients suffering from acute thrombotic microangiopathies

Journal of thrombosis and haemostasis, 2007-04, Vol.5 (4), p.866-867

2007

Link zum Volltext

Verfügbarkeit prüfen

VH1‐69 germline encoded antibodies directed towards ADAMTS13 in patients with acquired thrombotic thrombocytopenic purpura

Journal of thrombosis and haemostasis, 2009-03, Vol.7 (3), p.421-428

2009

Link zum Volltext

Verfügbarkeit prüfen

O-6

Fertility and sterility, 2006-09, Vol.86 (3), p.S3

2006

Link zum Volltext

Verfügbarkeit prüfen

Multiple B‐cell clones producing antibodies directed to the spacer and disintegrin/thrombospondin type‐1 repeat 1 (TSP1) of ADAMTS13 in a patient with acquired thrombotic thrombocytopenic purpura

Journal of thrombosis and haemostasis, 2006-11, Vol.4 (11), p.2355-2364

2006

Link zum Volltext

Verfügbarkeit prüfen

O-6: Who is at risk of developing emotional problems after in vitro fertilization (IVF): Pre treatment identification of risk groups

Fertility and sterility, 2006, Vol.86 (3), p.S3-S3

2006

Link zum Volltext

Verfügbarkeit prüfen

Prospective Randomized Multicenter Study of Clomiphene Citrate Versus Recombinant FSH for Ovarian Hyperstimulation and IUI in Unexplained and Male Subfertility

Fertility and sterility, 2005-09, Vol.84, p.S238-S238

2005

Link zum Volltext

Verfügbarkeit prüfen

A new tool to further explore the role of ADAMTS‐13 in health and disease

Journal of thrombosis and haemostasis, 2006-05, Vol.4 (5), p.952-954

2006

Link zum Volltext

Verfügbarkeit prüfen

Soluble thrombomodulin in patients with established atherosclerosis

Journal of thrombosis and haemostasis, 2004-01, Vol.2 (1), p.200-201

2004

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 70

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(65)
Mit Volltextzugriff
(66)

Publikationsform

Artikel
(67)
Buchkapitel
(3)

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Pathophysiology of thrombotic thrombocytopenic purpura and hemolytic uremic syndrome

High prevalence of hereditary thrombotic thrombocytopenic purpura in central Norway: from clinical observation to evidence

Recombinant ADAMTS13 normalizes von Willebrand factor‐cleaving activity in plasma of acquired TTP patients by overriding inhibitory antibodies

ADAMTS‐13, von Willebrand factor and related parameters in severe sepsis and septic shock

Second international collaborative study evaluating performance characteristics of methods measuring the von Willebrand factor cleaving protease (ADAMTS‐13)

Morphology studies in type 2 globozoospermia

Caplacizumab reduces the frequency of major thromboembolic events, exacerbations and death in patients with acquired thrombotic thrombocytopenic purpura

Plasma DNA is elevated in patients with deep vein thrombosis

Humoral immune response to ADAMTS13 in acquired thrombotic thrombocytopenic purpura

Impaired DNase1‐mediated degradation of neutrophil extracellular traps is associated with acute thrombotic microangiopathies

IgG subclass distribution of anti‐ADAMTS13 antibodies in patients with acquired thrombotic thrombocytopenic purpura

CLINICAL ASPECTS OF HEREDITARY AND ACQUIRED THROMBOTIC THROMBOCYTOPENIC PURPURA

Establishment of the WHO 1st International Standard ADAMTS13, plasma (12/252): communication from the SSC of the ISTH

Von Willebrand factor binds to surface-bound C1q in vitro

THE DYNAMIC RANGE OF IMMUNOASSAYS FOR HEPARIN-INDUCED THROMBOCYTOPENIA

Thrombotic thrombocytopenic purpura

Measurement of ADAMTS‐13 activity in plasma by the FRETS‐VWF73 assay: comparison with other assay methods

Hyperbilirubinemia interferes with ADAMTS‐13 activity measurement by FRETS‐VWF73 assay: diagnostic relevance in patients suffering from acute thrombotic microangiopathies

VH1‐69 germline encoded antibodies directed towards ADAMTS13 in patients with acquired thrombotic thrombocytopenic purpura

O-6

Multiple B‐cell clones producing antibodies directed to the spacer and disintegrin/thrombospondin type‐1 repeat 1 (TSP1) of ADAMTS13 in a patient with acquired thrombotic thrombocytopenic purpura

O-6: Who is at risk of developing emotional problems after in vitro fertilization (IVF): Pre treatment identification of risk groups

Prospective Randomized Multicenter Study of Clomiphene Citrate Versus Recombinant FSH for Ovarian Hyperstimulation and IUI in Unexplained and Male Subfertility

A new tool to further explore the role of ADAMTS‐13 in health and disease

Soluble thrombomodulin in patients with established atherosclerosis

Suchergebnisse filtern